positive
Recently
NephroPlus IPO Gets SEBI Nod to Raise ₹353.4 Crore
NephroPlus secures SEBI approval for a ₹353.4 cr IPO to expand dialysis network and cut debt.
Securities and Exchange Board of India (SEBI) has approved an IPO for Nephrocare Health Services, which runs the NephroPlus dialysis network. The IPO comprises a fresh issue of ₹353.4 crore plus an offer-for-sale (OFS) of 1.27 crore shares by existing shareholders.
NephroPlus plans to use proceeds to expand its dialysis clinics domestically as well as to repay debt. The Hyderabad-based firm operates over 500 centres globally across India, Nepal, Philippines, and Uzbekistan.